falsefalse

How Has Immunotherapy Evolved in the Advanced NSCLC Setting?

, ,

Thoracic Night Live | <b>Reflections on the Pivotal Lung Cancer Data of 2021</b>

Josh Sabari, MD; Nicholas C. Rohs, MD; and Balazs Halmos, MD, highlight new therapeutic advances in the advanced setting of non–small cell lung cancer unveiled throughout 2021.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected

    Josh Sabari, MD; Nicholas C. Rohs, MD; and Balazs Halmos, MD, highlight new therapeutic advances in the advanced setting of non–small cell lung cancer unveiled throughout 2021.

    Funding from Daiichi Sankyo/Content Independently Developed by OncLive


    x